Do not routinely use AFX2 endovascular grafts for patients with abdominal aortic aneurysms.Link to original article UPDATE: Impella RP System Post-Approval Study Results and Updated Labeling - Letter to Health Care Providers Update on Endologix AFX Endovascular AAA Graft Systems and Risk of Type III Endoleak: FDA Safety Communication Share Print Please login or register to post comments.